Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVS CVS Health	$67.38 +1.2%	$65.11	$43.56 ▼ $72.51	$85.30B	0.57	10.85 million shs	3.77 million shs
ISRG Intuitive Surgical	$543.74 +0.6%	$537.11	$413.82 ▼ $616.00	$195.15B	1.64	1.67 million shs	704,815 shs
JNJ Johnson & Johnson	$155.90 +0.2%	$153.68	$140.68 ▼ $169.99	$375.37B	0.41	8.06 million shs	3.48 million shs

10 Stocks Set to Soar in Summer 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVS CVS Health	0.00%	-1.65%	+6.00%	+6.03%	+18.83%
ISRG Intuitive Surgical	0.00%	+1.88%	-2.55%	+20.41%	+25.05%
JNJ Johnson & Johnson	0.00%	+2.27%	+1.64%	+1.88%	+7.06%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CVS CVS Health	4.9832 of 5 stars	3.5	3.0	3.3	3.9	2.3	3.3	3.1
ISRG Intuitive Surgical	4.3323 of 5 stars	2.4	3.0	0.0	4.0	3.0	2.5	1.9
JNJ Johnson & Johnson	4.8498 of 5 stars	2.3	5.0	4.2	3.9	3.1	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVS CVS Health	2.95	Moderate Buy	$75.38	11.87% Upside
ISRG Intuitive Surgical	2.70	Moderate Buy	$588.95	8.32% Upside
JNJ Johnson & Johnson	2.55	Moderate Buy	$170.88	9.61% Upside

Current Analyst Ratings Breakdown

Latest JNJ, ISRG, and CVS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/30/2025	CVS CVS Health	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$74.00 ➝ $80.00
6/9/2025	ISRG Intuitive Surgical	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Sell	$515.00 ➝ $440.00
6/5/2025	ISRG Intuitive Surgical	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
6/5/2025	JNJ Johnson & Johnson	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$181.00
6/2/2025	CVS CVS Health	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Overweight ➝ Overweight	$82.00 ➝ $79.00
5/22/2025	ISRG Intuitive Surgical	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$590.00 ➝ $650.00
5/13/2025	JNJ Johnson & Johnson	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
5/13/2025	JNJ Johnson & Johnson	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform	$169.00 ➝ $153.00
5/12/2025	CVS CVS Health	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$82.00 ➝ $84.00
5/6/2025	CVS CVS Health	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$76.00 ➝ $84.00
5/5/2025	CVS CVS Health	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy

(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVS CVS Health	$372.81B	0.23	$9.08 per share	7.42	$60.18 per share	1.12
ISRG Intuitive Surgical	$8.35B	23.33	$7.98 per share	68.16	$46.41 per share	11.72
JNJ Johnson & Johnson	$88.82B	4.22	$13.11 per share	11.89	$29.69 per share	5.25

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVS CVS Health	$4.61B	$4.19	10.60	9.95	0.97	1.39%	10.59%	3.17%	7/31/2025 (Estimated)
ISRG Intuitive Surgical	$2.32B	$6.82	85.47	71.26	5.78	28.41%	14.43%	12.81%	7/17/2025 (Estimated)
JNJ Johnson & Johnson	$14.07B	$8.99	15.52	14.08	2.36	24.42%	33.46%	13.30%	7/16/2025 (Estimated)

Latest JNJ, ISRG, and CVS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/31/2025	Q2 2025	CVS CVS Health	$1.45	N/A	N/A	N/A	$94.87 billion	N/A
7/17/2025	Q2 2025	ISRG Intuitive Surgical	$1.92	N/A	N/A	N/A	$2.35 billion	N/A
7/16/2025	Q2 2025	JNJ Johnson & Johnson	$2.65	N/A	N/A	N/A	$22.85 billion	N/A
5/1/2025	Q1 2025	CVS CVS Health	$1.62	$2.25	+$0.63	$1.41	$93.07 billion	$94.59 billion
4/22/2025	Q1 2025	ISRG Intuitive Surgical	$1.71	$1.81	+$0.10	$1.92	$2.19 billion	$2.25 billion
4/15/2025	Q1 2025	JNJ Johnson & Johnson	$2.59	$2.77	+$0.18	$4.54	$21.65 billion	$21.89 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVS CVS Health	$2.66	3.95%	N/A	63.48%	4 Years
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
JNJ Johnson & Johnson	$5.20	3.34%	N/A	57.84%	64 Years

Latest JNJ, ISRG, and CVS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/15/2025	JNJ Johnson & Johnson	quarterly	$1.30	3.37%	5/27/2025	5/27/2025	6/10/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVS CVS Health	0.77	0.82	0.63
ISRG Intuitive Surgical	N/A	4.98	3.97
JNJ Johnson & Johnson	0.49	1.26	1.03

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CVS CVS Health	80.66%
ISRG Intuitive Surgical	83.64%
JNJ Johnson & Johnson	69.55%

Insider Ownership

Company	Insider Ownership
CVS CVS Health	1.22%
ISRG Intuitive Surgical	0.70%
JNJ Johnson & Johnson	0.16%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CVS CVS Health	300,000	1.27 billion	1.25 billion	Optionable
ISRG Intuitive Surgical	15,638	358.42 million	355.91 million	Optionable
JNJ Johnson & Johnson	138,100	2.41 billion	2.40 billion	Optionable

JNJ, ISRG, and CVS Headlines

Recent News About These Companies

Johnson & Johnson Canadian Depository Receipt (CAD Hedged) JNJ

3 hours ago | morningstar.comM

Tandem Investment Advisors Inc. Trims Stock Holdings in Johnson & Johnson (NYSE:JNJ)

July 5 at 5:29 AM | marketbeat.com

Meritage Portfolio Management Sells 1,844 Shares of Johnson & Johnson (NYSE:JNJ)

July 5 at 5:24 AM | marketbeat.com

ZWJ Investment Counsel Inc. Buys 2,851 Shares of Johnson & Johnson (NYSE:JNJ)

July 5 at 5:24 AM | marketbeat.com

Resonant Capital Advisors LLC Increases Stake in Johnson & Johnson (NYSE:JNJ)

July 5 at 5:23 AM | marketbeat.com

Robert Wood Johnson Foundation Trims Stock Position in Johnson & Johnson (NYSE:JNJ)

July 5 at 5:23 AM | marketbeat.com

Teacher Retirement System of Texas Lowers Position in Johnson & Johnson (NYSE:JNJ)

July 5 at 5:21 AM | marketbeat.com

First Horizon Advisors Inc. Raises Stock Position in Johnson & Johnson (NYSE:JNJ)

July 5 at 5:09 AM | marketbeat.com

Revisor Wealth Management LLC Has $892,000 Stake in Johnson & Johnson (NYSE:JNJ)

July 5 at 5:09 AM | marketbeat.com

Hudson Edge Investment Partners Inc. Has $6.66 Million Stock Position in Johnson & Johnson (NYSE:JNJ)

July 5 at 5:09 AM | marketbeat.com

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

July 4 at 9:56 AM | zacks.com

2 Bulletproof Dividend Stocks to Buy in July

July 4 at 9:40 AM | 247wallst.com

Goldman Sachs Rates Johnson & Johnson a Buy, Citing Pipeline Strength and Policy Tailwinds

July 4 at 6:48 AM | msn.com

Pinnacle Financial Partners Inc Boosts Stock Position in Johnson & Johnson (NYSE:JNJ)

July 4 at 5:05 AM | marketbeat.com

Miller Howard Investments Inc. NY Acquires 99,040 Shares of Johnson & Johnson (NYSE:JNJ)

July 4 at 5:05 AM | marketbeat.com

Kanawha Capital Management LLC Has $24.87 Million Stock Holdings in Johnson & Johnson (NYSE:JNJ)

July 4 at 5:05 AM | marketbeat.com

Moody Lynn & Lieberson LLC Has $22.09 Million Stock Position in Johnson & Johnson (NYSE:JNJ)

July 4 at 5:05 AM | marketbeat.com

First Bank & Trust Buys 3,952 Shares of Johnson & Johnson (NYSE:JNJ)

July 4 at 5:04 AM | marketbeat.com

Harbour Trust & Investment Management Co Cuts Stock Position in Johnson & Johnson (NYSE:JNJ)

July 4 at 5:04 AM | marketbeat.com

Johnson & Johnson (NYSE:JNJ) Shares Sold by Keybank National Association OH

July 4 at 4:54 AM | marketbeat.com

Yukon Wealth Management Inc. Invests $741,000 in Johnson & Johnson (NYSE:JNJ)

July 4 at 4:54 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
Intel's Turnaround Strategy Shifts From Planning to Attack Mode
By Jeffrey Neal Johnson | June 20, 2025
View Intel's Turnaround Strategy Shifts From Planning to Attack Mode
Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?
By Leo Miller | June 19, 2025
View Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?

JNJ, ISRG, and CVS Company Descriptions

CVS Health NYSE:CVS

$67.38 +0.78 (+1.16%)

Closing price 07/3/2025 03:59 PM Eastern

Extended Trading

$67.38 0.00 (0.00%)

As of 07/3/2025 04:46 PM Eastern

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Intuitive Surgical NASDAQ:ISRG

$543.74 +3.14 (+0.58%)

Closing price 07/3/2025 03:51 PM Eastern

Extended Trading

$543.08 -0.66 (-0.12%)

As of 07/3/2025 04:54 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Johnson & Johnson NYSE:JNJ

$155.90 +0.34 (+0.22%)

Closing price 07/3/2025 03:59 PM Eastern

Extended Trading

$155.75 -0.15 (-0.10%)

As of 07/3/2025 04:59 PM Eastern

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time